Dimensional Fund Advisors’s Apyx Medical APYX Stock Holding History

Dimensional Fund Advisors’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-24,664	Closed	-$52.8K	–	3248
2025 Q3	$52.8K	Sell	24,664 -50,635	-67%	-$107K	﹤0.01%	3237
2025 Q2	$169K	Sell	75,299 -24,001	-24%	-$33.8K	﹤0.01%	3137
2025 Q1	$136K	Sell	99,300 -8,982	-8%	-$12.4K	﹤0.01%	3166
2024 Q4	$171K	Hold	108,282	–	–	﹤0.01%	3182
2024 Q3	$134K	Sell	108,282 -17,545	-14%	-$22.2K	﹤0.01%	3218
2024 Q2	$169K	Sell	125,827 -140,030	-53%	-$207K	﹤0.01%	3190
2024 Q1	$362K	Sell	265,857 -83,336	-24%	-$177K	﹤0.01%	3103
2023 Q4	$915K	Buy	349,193 +27,867	+9%	+$67.5K	﹤0.01%	2945
2023 Q3	$1.03M	Sell	321,326 -40,491	-11%	-$189K	﹤0.01%	2919
2023 Q2	$1.82M	Sell	361,817 -1,249	-0.3%	-$6.33K	﹤0.01%	2805
2023 Q1	$1.05M	Sell	363,066 -10,043	-3%	-$29.3K	﹤0.01%	2895
2022 Q4	$872	Sell	373,109 -78,207	-17%	-$239K	﹤0.01%	2928
2022 Q3	$2.03M	Sell	451,316 -48,784	-10%	-$349K	﹤0.01%	2709
2022 Q2	$2.93M	Sell	500,100 -27,007	-5%	-$139K	﹤0.01%	2625
2022 Q1	$3.44M	Hold	527,107	–	–	﹤0.01%	2652
2021 Q4	$6.76M	Buy	527,107 +2,446	+0.5%	+$34.2K	﹤0.01%	2465
2021 Q3	$7.27M	Buy	524,661 +37,708	+8%	+$397K	﹤0.01%	2456
2021 Q2	$5.02M	Buy	486,953 +75,003	+18%	+$743K	﹤0.01%	2609
2021 Q1	$3.98M	Buy	411,950 +33,391	+9%	+$334K	﹤0.01%	2650
2020 Q4	$2.73M	Buy	378,559 +10,656	+3%	+$70.6K	﹤0.01%	2720
2020 Q3	$1.73M	Buy	367,903 +6,481	+2%	+$32.1K	﹤0.01%	2781
2020 Q2	$2.01M	Buy	361,422 +14,128	+4%	+$58.7K	﹤0.01%	2756
2020 Q1	$1.25M	Buy	347,294 +40,532	+13%	+$272K	﹤0.01%	2842
2019 Q4	$2.6M	Sell	306,762 -13,491	-4%	-$97.5K	﹤0.01%	2794
2019 Q3	$2.17M	Sell	320,253 -96,004	-23%	-$681K	﹤0.01%	2842
2019 Q2	$2.79M	Buy	416,257 +115,492	+38%	+$628K	﹤0.01%	2813
2019 Q1	$1.9M	Buy	300,765 +166,267	+124%	+$1.29M	﹤0.01%	2904
2018 Q4	$871K	Buy	134,498 +43,727	+48%	+$265K	﹤0.01%	3044
2018 Q3	$644K	Hold	90,771	–	–	﹤0.01%	3138
2018 Q2	$395K	Sell	90,771 -88,422	-49%	-$326K	﹤0.01%	3157
2018 Q1	$532K	Hold	179,193	–	–	﹤0.01%	3095
2017 Q4	$466K	Sell	179,193 -4,634	-3%	-$14.5K	﹤0.01%	3105
2017 Q3	$621K	Sell	183,827 -7,644	-4%	-$19.7K	﹤0.01%	3075
2017 Q2	$473K	Sell	191,471 -39,637	-17%	-$97.4K	﹤0.01%	3101
2017 Q1	$617K	Sell	231,108 -21,200	-8%	-$70.4K	﹤0.01%	3063
2016 Q4	$906K	Sell	252,308 -23,035	-8%	-$103K	﹤0.01%	2989
2016 Q3	$1.44M	Sell	275,343 -3,600	-1%	-$11.7K	﹤0.01%	2858
2016 Q2	$457K	Sell	278,943 -300	-0.1%	-$521	﹤0.01%	3069
2016 Q1	$466K	Hold	279,243	–	–	﹤0.01%	3060
2015 Q4	$586K	Sell	279,243 -17,584	-6%	-$34K	﹤0.01%	3057
2015 Q3	$588K	Sell	296,827 -1,323	-0.4%	-$3.03K	﹤0.01%	3093
2015 Q2	$832K	Sell	298,150 -47,501	-14%	-$131K	﹤0.01%	3058
2015 Q1	$826K	Sell	345,651 -3,334	-1%	-$11.1K	﹤0.01%	3024
2014 Q4	$1.27M	Sell	348,985 -12,900	-4%	-$50.1K	﹤0.01%	2953
2014 Q3	$1.44M	Sell	361,885 -1,200	-0.3%	-$4.87K	﹤0.01%	2929
2014 Q2	$1.32M	Sell	363,085 -2,500	-0.7%	-$10.1K	﹤0.01%	2973
2014 Q1	$1.41M	Hold	365,585	–	–	﹤0.01%	2948
2013 Q4	$775K	Hold	365,585	–	–	﹤0.01%	3080
2013 Q3	$1.03M	Buy	365,585 +717	+0.2%	+$2.19K	﹤0.01%	3037
2013 Q2	$1.08M	Buy	+364,868	New	+$1.23M	﹤0.01%	3006

Other funds holding APYX

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Dimensional Fund Advisors's APYX Position: Q4 2025 in Review

Dimensional Fund Advisors sold out of Apyx Medical (APYX) in Q4 2025, closing a stake of 24,664 shares — an estimated $52.8K sold.

Dimensional Fund Advisors first reported a position in APYX in Q2 2013 and held it in 50 quarters. The position peaked at $7.27M in Q3 2021. 59 funds tracked by Wall St. Rank hold APYX as of Q4 2025.

Dimensional Fund Advisors reported no remaining Apyx Medical position as of Q4 2025 after selling out during the quarter.
Dimensional Fund Advisors sold 24,664 Apyx Medical shares in Q4 2025, an estimated $52.8K.
Dimensional Fund Advisors first reported a position in Apyx Medical in Q2 2013 and held it in 50 quarters.
Dimensional Fund Advisors's Apyx Medical position peaked at $7.27M in Q3 2021.
59 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2025.

Based on Dimensional Fund Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.